Skip to main content

Peer Review reports

From: Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality

Original Submission
21 Jan 2022 Submitted Original manuscript
31 Mar 2022 Reviewed Reviewer Report
2 Apr 2022 Reviewed Reviewer Report
16 Apr 2022 Author responded Author comments - Qian Zhou
Resubmission - Version 2
16 Apr 2022 Submitted Manuscript version 2
4 May 2022 Reviewed Reviewer Report
14 Dec 2022 Reviewed Reviewer Report
13 Jan 2023 Author responded Author comments - Qian Zhou
Resubmission - Version 3
13 Jan 2023 Submitted Manuscript version 3
28 Jan 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
21 Feb 2023 Editorially accepted
8 Mar 2023 Article published 10.1186/s12890-023-02367-x

You can find further information about peer review here.

Back to article page